Dr. Nahid Turan, principal investigator of the NIGMS Repository at Coriell, provided her insights during a precision medicine conference.
read moreA cell line from the NIGMS Repository at Coriell has yielded a DNA sample that can serve as an international research standard.
read moreCoriell Institute for Medical Research, home to the world's most diverse biobank and a leading center for cutting-edge scientific exploration, has won a $14 million grant through an open competition from the National Institute of General Medical Sciences, a component of the National Institutes of Health.
read moreAlready the world's leading source for human induced pluripotent stem cell lines, Coriell has reached a significant benchmark with its program.
read moreA reporter with the Wall Street Journal investigating the relationship between the Ebola virus disease and a rare genetic disorder referenced Coriell's world-renowned biobank.
read moreScientists from elite institutions all around the country are using biospecimens from the world-renowned Coriell Institute Biobank to conduct meaningful Ebola virus disease research.
read moreThe Personal Genome Project (PGP) is a long-term, large cohort study that aims to sequence and publicize the complete genomes and medical records of thousands of participants in order to enable personal genomics and personalized medicine research.
read moreThe NIGMS Human Genetic Cell Repository has genotyped more than 1000 Repository cell lines with the Affymetrix Genome-Wide Human SNP Array 6.0 platform.
read moreTo facilitate research on differentiated cell types and other biomedical investigations, the NIGMS Repository offers human induced pluripotent stem cell (iPSC) lines derived from apparently healthy individuals or from
read morePatient advocacy organizations and research investigators can now take advantage of a new integrated registry and repository resource to further advance rare disease research. Blood or tissue samples donated to the NIGMS Human Genetic Cell Repository at the Coriell Institute for Medical Research can be linked to de‐identified clinical data in patient registries built by PatientCrossroads. The samples and corresponding clinical information are then made available to the international scientific community for use in basic research, gene discovery and the development of potential treatments.
read more